Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/15/2023 17:00 EST Earnings Call Q4 2022 -- -- --
02/15/2023 -- Results Q4 2022 -- 1.42 --
11/02/2022 17:00 EST Earnings Call Q3 2022 -- -- --
11/02/2022 -- Results Q3 2022 1.85 0.69 167.0%
08/04/2022 17:00 EST Earnings Call Q2 2022 -- -- --
08/04/2022 -- Results Q2 2022 2.34 2.68 -12.69%
05/04/2022 17:00 EST Earnings Call Q1 2022 -- -- --
05/04/2022 -- Results Q1 2022 11.66 9.43 23.69%
*Estimated Date/Time

Earnings

Next Report Date 02/15/2023
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/02/2022
Beat/Miss Upgrade
Return Since -3.52%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company's comprehensive product portfolio covers a wide range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and a host of clinical and at-home products to detect COVID-19.
URL https://www.ir.quidelortho.com
Investor Relations URL https://ir.quidel.com/
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Feb. 15, 2023
Last Earnings Release Nov. 02, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
1.04%
102.4%
12.62%
53.69%
139.4%
-24.86%
-36.54%
-0.07%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
6.28%
30.40%
24.59%
16.84%
26.27%
13.10%
15.33%
-21.06%
5.53%
-12.32%
52.00%
29.04%
22.10%
28.00%
30.54%
-20.69%
1.15%
9.23%
31.23%
6.62%
22.20%
-6.75%
1.88%
2.51%
-0.82%
--
--
81.76%
34.72%
-12.22%
45.12%
-33.63%
18.63%
As of January 31, 2023.

Profile

Edit
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company's comprehensive product portfolio covers a wide range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and a host of clinical and at-home products to detect COVID-19.
URL https://www.ir.quidelortho.com
Investor Relations URL https://ir.quidel.com/
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Feb. 15, 2023
Last Earnings Release Nov. 02, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
GERM 829008.0 USD 3.57%
HVAX.TO 72034.00 USD 3.28%
AOFCX 83.94M USD 2.86%
MSGCX 18.64M USD 2.51%
MRCGX 32.87M USD 2.47%
FHH.F.TO 385227.0 USD 2.22%
FXH 33.30M USD 2.03%
TDB3505 8.840M USD 1.73%
JSMD 2.566M USD 1.35%
DJT00675 15.20M USD 1.03%
ZGEN.TO 30623.00 USD 0.70%
FSCFX 39.35M USD 0.51%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter QDEL Tweets